close

KBRA Releases Research — Litigation Finance ABS: Not Settling for Less

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

KBRA releases research on the characteristics and key concepts related to litigation finance ABS, which has seen increasing issuance volume. KBRA has rated 12 litigation finance ABS transactions across six different sponsors since 2020.

KBRA-rated litigation finance ABS transactions are primarily collateralized by advances made to plaintiffs against potential future settlements of cases, primarily relating to personal injury. Certain transactions also include advances made to medical service providers, which are required to be repaid with case proceeds. The pools of advances backing the ABS are characterized by diversification of cases, plaintiffs, law firms, and payors. The ABS structures typically include a pool balance calculation that gives credit to collections above the funded amount as well as full turbo payment priorities.

Click here to view the report.

About KBRA

KBRA is a full-service credit rating agency registered in the U.S., the EU, and the UK, and is designated to provide structured finance ratings in Canada. KBRA’s ratings can be used by investors for regulatory capital purposes in multiple jurisdictions.

Contacts

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  252.11
-4.86 (-1.89%)
AAPL  313.95
-2.27 (-0.72%)
AMD  523.75
+18.01 (3.56%)
BAC  62.81
+0.42 (0.68%)
GOOG  328.01
-7.37 (-2.20%)
META  650.41
+36.93 (6.02%)
MSFT  492.90
-1.05 (-0.21%)
NVDA  224.22
-1.51 (-0.67%)
ORCL  162.11
-0.41 (-0.26%)
TSLA  369.20
+1.04 (0.28%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Starting at /week.